U.S. Kidney Dialysis Clinics Industry Worth $24 Billion

July 15, 2019:   Marketdata LLC, a leading independent market research publisher of “off-the-shelf” studies about service industries since 1979, has released a new 82-page study: U.S. Kidney Dialysis Clinics: An Industry Analysis . This is a complete analysis and forecast of kidney dialysis centers—the nature and structure and size of the market, key issues, trends, operations and competitors.
 
“Kidney dialysis is a life or death, crucial healthcare service that costs about $90,000 a year per patient. The large competitors have enjoyed a near monopoly for years, but changes are coming that could hamper that growth and profitability.”, according to Research Director, John LaRosa.
 
Major Findings:
 

Market Value…  Marketdata estimates that the U.S. kidney dialysis industry was worth $24.7 billion in 2018, up 5.5% from 2017. The total market is forecast to grow at a 4.0 % average annual pace, to $29.7 billion by 2023. Revenue growth has been moderate since 2011—about 3-5% annual gains.
 
There are an estimated 7,500 clinics providing kidney dialysis services in the United States. Average annual receipts per clinic are $3.3 million, and they have an 18% net profit margin.

The demand for kidney dialysis is rising, in America and especially abroad, as the population ages, obesity levels rise or remain at high levels, and the number of Americans with diabetes, pre-diabetes, and hypertension rises.
 
According to the United States Renal Data System (USRDS), there were over 511,000 ESRD (end stage renal disease) dialysis patients in the U.S. in 2016. Based on the most recent 2018 annual data, the underlying ESRD dialysis patient population has grown at a compound rate of 3.8% from 2000 to 2016.  
 
This industry is very concentrated, as the 4 largest firms in the industry capture more than 85% of revenues. Two companies, Davita Partners in the U.S. and Fresenius Medical Care, based in Germany, basically control the market.  DaVita had 2018 revenues of $9.9 billion and Fresenius had revenues of $10.6 billion. These companies have been investigated and fined with regard to their practices and overbilling of Medicare insurance.
 
A major source of payment for the clinics’ services is Medicare. President Trump just signed a new executive order to increase the number of organ donations and spur development of artificial kidneys, and shift services to more home care, in an effort to cut Medicare spending in this area.
 
Several factors that could dampen revenue growth for kidney dialysis clinics over the next four years include: increased access to kidney transplants by patients, new payment models that favor home dialysis over clinic-based treatment, resulting in Medicare reimbursement cuts, and possible staff shortages and unionization of clinic technicians.
 

About The Report
 
U.S. Kidney Dialysis Clinics: An Industry Analysis , published in July 2019, is an independently researched “off-the-shelf” study.  The study is 82 pages in length and costs $995.  Available in pdf format. A free table of contents is available by email Contact: Marketdata LLC, 7210 Wareham Drive, Tampa, FL  33647, (813) 971-8080. John LaRosa is available for interviews.
 
About Marketdata LLC
 
Marketdata is a private market research and consulting firm that has specialized in the tracking and analysis of a wide variety of service industry and healthcare sectors. The company also provides custom research and consulting services, and holds teleconferences and webinars. It has a 30-year specialty tracking the weight loss market. The company website is: www.marketdataenterprises.com.
 
 
 

Contact Information

John S. LaRosa

Research Director

Marketdata LLC

(1) 8139718080

marketdataent@yahoo.com